{
  "id": 18230185,
  "title": "Arcutis Biotherapeutics CEO Todd Watanabe sells $139,466 in stock",
  "url": "https://urgent.news/2026/11/05/arcutis-biotherapeutics-ceo-todd-watanabe-sells-139-466-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-05T02:30:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/arcutis-biotherapeutics-ceo-todd-watanabe-sells-139466-in-stock-93CH-5002053"
  },
  "original_language": "en",
  "account": "Arcutis Biotherapeutics CEO Todd Watanabe sold 4,377 shares of the company's common stock on November 2, 2026, amounting to $139,466. The shares were sold at an average price of $31.86, ranging from $31.57 to $32.23. The transaction was to cover tax withholding obligations for the vesting of Restricted Stock Units. Since the sale, Arcutis Biotherapeutics stock has increased to $34.05, near its 52-week high of $34.80, indicating a 45% gain over the past six months. Analysts suggest the stock is slightly overvalued at current levels. Watanabe retains a substantial stake in the company, holding 712,826 shares directly and 25,410 shares indirectly through four trusts and two private companies. Despite a revenue beat of $143.9 million in Q3 2026, the company's adjusted earnings for the period were $0.06 per share, far below the expected $0.18 per share, impacting investor sentiment. The earnings miss led to a significant post-market decline in the stock price. The company's focus now revolves around balancing revenue growth with profitability.",
  "summary": null,
  "key_points": [
    "CEO Todd Watanabe sold 4,377 shares worth $139,466 on November 2, 2026",
    "Sale price averaged $31.86 per share, within $31.57-$32.23 range",
    "Stock rose to $34.05 post-sale, indicating 45% gain in six months"
  ],
  "editors_take": "The CEO's sale to cover tax obligations occurs as the company struggles to translate strong revenue growth into the profitability levels expected by investors.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}